Natalie A. Terry

1.7k total citations
37 papers, 1.1k citations indexed

About

Natalie A. Terry is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Natalie A. Terry has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 16 papers in Surgery and 11 papers in Epidemiology. Recurrent topics in Natalie A. Terry's work include Inflammatory Bowel Disease (17 papers), Microscopic Colitis (10 papers) and Eosinophilic Esophagitis (6 papers). Natalie A. Terry is often cited by papers focused on Inflammatory Bowel Disease (17 papers), Microscopic Colitis (10 papers) and Eosinophilic Esophagitis (6 papers). Natalie A. Terry collaborates with scholars based in United States, Canada and Italy. Natalie A. Terry's co-authors include Kara Gross Margolis, Gary D. Wu, Arthur Kastl, Lindsey Albenberg, Tracy L. Kress, James M. Denegre, Kimberly L. Mowry, Colette Côté, Denise Gautreau and Stephen DiNardo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular Cell and Gastroenterology.

In The Last Decade

Natalie A. Terry

33 papers receiving 1.1k citations

Peers

Natalie A. Terry
Jeroen Visser Netherlands
Christina L. Hirota Canada
Marie Louise Grøndahl Denmark
Xiaojing Zhao China
Michela Miani Belgium
Alice Bertocchi Italy
Ruqi Tang China
Bosheng Qiu United States
Émilie Stolarczyk United Kingdom
Jeroen Visser Netherlands
Natalie A. Terry
Citations per year, relative to Natalie A. Terry Natalie A. Terry (= 1×) peers Jeroen Visser

Countries citing papers authored by Natalie A. Terry

Since Specialization
Citations

This map shows the geographic impact of Natalie A. Terry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie A. Terry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie A. Terry more than expected).

Fields of papers citing papers by Natalie A. Terry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie A. Terry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie A. Terry. The network helps show where Natalie A. Terry may publish in the future.

Co-authorship network of co-authors of Natalie A. Terry

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie A. Terry. A scholar is included among the top collaborators of Natalie A. Terry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie A. Terry. Natalie A. Terry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Danese, Silvio, Bruce E. Sands, Anita Afzali, et al.. (2025). P0669 Safety of intravenous and subcutaneous guselkumab induction administration: Results from the GALAXI and GRAVITI studies in participants with Crohn’s Disease. Journal of Crohn s and Colitis. 19(Supplement_1). i1308–i1309. 1 indexed citations
2.
Hart, A, Flávio Steinwurz, Silvio Danese, et al.. (2025). OP33 Efficacy and safety of subcutaneous guselkumab induction therapy in patients with moderately to severely active Crohn’s disease: Results through Week 48 from the phase 3 GRAVITI study. Journal of Crohn s and Colitis. 19(Supplement_1). i66–i67. 1 indexed citations
3.
Panés, Julián, Tadakazu Hisamatsu, Alessandro Armuzzi, et al.. (2025). P0917 Corticosteroid sparing effects of treatment with guselkumab in patients with moderate to severely active Crohn’s disease: Phase 3 GALAXI 2/3 results through week 48. Journal of Crohn s and Colitis. 19(Supplement_1). i1724–i1725. 2 indexed citations
4.
Panaccione, Remo, Silvio Danese, Brian G. Feagan, et al.. (2024). EFFICACY AND SAFETY OF GUSELKUMAB THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS OF THE GALAXI 2 & 3 PHASE 3 STUDIES. Gastroenterology. 166(5). 1057b–1057b2. 22 indexed citations
5.
Sands, Bruce E., Geert D’Haens, Silvio Danese, et al.. (2024). S1445 Efficacy of Guselkumab vs Placebo in Crohn’s Disease Based on Prior Response/Exposure to Biologic Therapy: Results of the GALAXI 2 and 3 Phase 3 Studies. The American Journal of Gastroenterology. 119(10S). S1039–S1040. 1 indexed citations
6.
Steinwurz, Flávio, Silvio Danese, Tadakazu Hisamatsu, et al.. (2024). S1052 Efficacy and Safety of Subcutaneous Guselkumab Induction Therapy in Patients With Moderately to Severely Active Crohn’s Disease: Results Through Week 48 From the Phase 3 GRAVITI Study. The American Journal of Gastroenterology. 119(10S). S740–S741. 8 indexed citations
7.
Danese, Silvio, Anita Afzali, Remo Panaccione, et al.. (2024). S1053 Week 48 Efficacy Of Guselkumab And Ustekinumab In Crohn’s Disease Based On Prior Response/Exposure To Biologic Therapy: Results From The GALAXI 2 and 3 Phase 3 Studies. The American Journal of Gastroenterology. 119(10S). S741–S742.
8.
9.
Danese, Silvio, Remo Panaccione, Brian G. Feagan, et al.. (2023). S851 Efficacy and Safety of Guselkumab for Crohn’s Disease Through 3 Years: GALAXI-1 Long-Term Extension. The American Journal of Gastroenterology. 118(10S). S630–S630. 1 indexed citations
10.
Rudrapatna, Vivek A., Yao‐Wen Cheng, Jonathan Shih, et al.. (2023). Creation of an ustekinumab external control arm for Crohn’s disease using electronic health records data: A pilot study. PLoS ONE. 18(3). e0282267–e0282267. 7 indexed citations
11.
Karakasheva, Tatiana A., Yusen Zhou, Hongbo Xie, et al.. (2023). Patient-derived Colonoids From Disease-spared Tissue Retain Inflammatory Bowel Disease-specific Transcriptomic Signatures. SHILAP Revista de lepidopterología. 2(6). 830–842. 4 indexed citations
12.
Kondo, Ayano, Michelle Y. Y. Lee, Daniel Traum, et al.. (2021). Highly Multiplexed Image Analysis of Intestinal Tissue Sections in Patients With Inflammatory Bowel Disease. Gastroenterology. 161(6). 1940–1952. 30 indexed citations
13.
Chumpitazi, Bruno P., Jeffery D. Lewis, Mauro D’Amato, et al.. (2020). Hypomorphic SI genetic variants are associated with childhood chronic loose stools. PLoS ONE. 15(5). e0231891–e0231891. 7 indexed citations
14.
Pahl, Matthew C., Diana L. Cousminer, Claudia A. Doege, et al.. (2020). Variant-to-Gene-Mapping Analyses Reveal a Role for the Hypothalamus in Genetic Susceptibility to Inflammatory Bowel Disease. Cellular and Molecular Gastroenterology and Hepatology. 11(3). 667–682. 13 indexed citations
15.
Kastl, Arthur, Natalie A. Terry, Gary D. Wu, & Lindsey Albenberg. (2019). The Structure and Function of the Human Small Intestinal Microbiota: Current Understanding and Future Directions. Cellular and Molecular Gastroenterology and Hepatology. 9(1). 33–45. 223 indexed citations
16.
Terry, Natalie A. & Kara Gross Margolis. (2016). Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance. Handbook of experimental pharmacology. 239. 319–342. 135 indexed citations
17.
Terry, Natalie A., et al.. (2013). Pancreatic α-Cell Specific Deletion of Mouse Arx Leads to α-Cell Identity Loss. PLoS ONE. 8(6). e66214–e66214. 68 indexed citations
18.
Du, Aiping, Kyle W. McCracken, Erik R. Walp, et al.. (2012). Arx is required for normal enteroendocrine cell development in mice and humans. Developmental Biology. 365(1). 175–188. 55 indexed citations
19.
Terry, Natalie A., Natalia Tulina, Erika Matunis, & Stephen DiNardo. (2006). Novel regulators revealed by profiling Drosophila testis stem cells within their niche. Developmental Biology. 294(1). 246–257. 85 indexed citations
20.
Côté, Colette, Denise Gautreau, James M. Denegre, et al.. (1999). A Xenopus Protein Related to hnRNP I Has a Role in Cytoplasmic RNA Localization. Molecular Cell. 4(3). 431–437. 203 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeroen Visser Breakdown of academic impact, for papers by Christina L. Hirota Breakdown of academic impact, for papers by Marie Louise Grøndahl Breakdown of academic impact, for papers by Xiaojing Zhao Breakdown of academic impact, for papers by Michela Miani Breakdown of academic impact, for papers by Alice Bertocchi Breakdown of academic impact, for papers by Ruqi Tang Breakdown of academic impact, for papers by Bosheng Qiu Breakdown of academic impact, for papers by Émilie Stolarczyk
Rankless by CCL
2026